EMA approves first ever malaria vaccine

China approves world's first oncolytic virus therapy for cancer treatment.

Oncolytic virus research got a welcome boost last November when Chinese regulators approved the world’s fi rst oncolytic viral therapy for cancer, Shanghai Sunway Biotech’s genetically modifi ed adenovirus H101. “ It’s fantastic for the fi eld, ” said John Bell , Ph.D., of the Ottawa Health Research Institute in Canada. “ We needed to have something that was a success, and so I think this is a ...

First DNA malaria vaccine on trial in Africa

Scientists from Oxford have taken another step along the frustrating route to an effective malaria vaccine. This autumn, Vasee Moorthy of Oxford University’s Department of Clinical Medicine, working with scientists at the Medical Research Council’s Laboratories in the Gambia, began trials of new DNA-based vaccines against the malaria parasite Plasmodium falciparum. The vaccines, developed by Ad...

Outcomes after first-ever stroke.

OBJECTIVES To determine the outcomes after first-ever stroke, including mortality, dependence, and recurrence. DESIGN Retrospective study on a prospectively collected cohort. SETTING Regional hospital, Hong Kong. PATIENTS A cohort of 755 patients presented to our hospital from 1996 to 1998 with their first-ever stroke. MAIN OUTCOME MEASURES Mortality and stroke recurrence rate at 30 day...

Designing a malaria vaccine.

Malaria vaccine developments.

Large gains in the reduction of malaria mortality in the early 20th century were lost in subsequent decades. Malaria now kills 2-3 million people yearly. Implementation of malaria control technologies such as insecticide-treated bednets and chemotherapy could reduce mortality substantially, but an effective malaria vaccine is also needed. Advances in vaccine technology and immunology are being ...